Nonhospitalized Long-Haul Coronavirus Patients Susceptible

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
309
Nonhospitalized Long-Haul Coronavirus Patients Susceptible to Cognitive Dysfunction

A group of researchers from the Feinberg School of Medicine at Northwestern University has discovered additional evidence of cognitive dysfunction in many coronavirus patients who were not hospitalized after contracting the infection. The group’s findings were reported in the “Annals of Clinical and Translational Neurology” journal.

In the study, the researchers looked into medical data of nonhospitalized coronavirus patients from 21 different states who were experiencing long-term symptoms of the coronavirus, documenting what they discovered from the study.

As the pandemic surges on, despite measures to contain it, media outlets have continued to report statistics on the number of mortalities and number of coronavirus infections. However, not much attention has been paid to individuals who were harmed by the deadly virus but not enough to be hospitalized. This is why the team of researchers decided to unearth more information about some of the long-term effects experienced by individuals who had contracted the infection, which is caused by the SARS-CoV-2 virus.

To discover more information about these patients who are now commonly referred to as long haulers, the researchers acquired the data of 100 patients from medical institutions in 21 states; the patients had all contracted the coronavirus but were not admitted to hospital. Some of these patients were seen in person with many visiting the Northwestern Memorial Hospital, which is located in Chicago, while others opted for the telehealth option. The researchers noted that nearly half of the data obtained involved patients who hadn’t been diagnosed with the infection but were believed to have been infected with the virus.

The team of researchers discovered that about 85% of the patients studied in their research revealed that they had at least four neurological symptoms, the most common of which were found to be tingling, numbness, headaches and brain fog. Other symptoms the researchers found to be common were ringing in the ears, dizziness, blurred vision and the loss of smell and/or taste. The researchers also noted that most of these patients described these symptoms as on and off, with many of them revealing that their symptoms lasted for several months, with some lasting for as long as nine months.

Additionally, the researchers discovered that the majority of the patients they observed reported that they felt anxious or depressed prior to their infection, which may suggest an increased risk of long-haul symptoms for individuals with similar conditions.

The researchers admitted that while their study was small, it was big enough to demonstrate that long haulers could possibly need more care than many researchers and health-care providers realize.

Another group that needs more care are patients suffering from cystic fibrosis as well as chronic pancreatitis, particularly those who develop exocrine pancreatic insufficiency (aka EPI). AzurRx BioPharma Inc. (NASDAQ: AZRX) is conducting clinical trials on a drug candidate that could help EPI patients get relief.

NOTE TO INVESTORS: The latest news and updates relating to AzurRx BioPharma Inc. (NASDAQ: AZRX) are available in the company’s newsroom at https://ibn.fm/AZRX

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer



Entero Therapeutics Inc. (ENTO) Stock Research Links

ENTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 112

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 136

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 292

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Crédit Agricole Assurances Reports Remarkable Growth in 2024

Updated Category News Views 81

Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...

Continue Reading
Enerpac Tool Group's Earnings Preview and Stock Insights

Updated Category News Views 72

Enerpac Tool Group's Upcoming Earnings Announcement Enerpac Tool Group (NYSE: EPAC) is set to release its quarterly earnings report shortly. This announcement is pivotal for both current investors and those considering an investment in the company. With analysts predicting an earnings per share (EPS) of $0.53, excitement is building around whether Enerpac will meet or...

Continue Reading
Unlocking Sales Potential: The Power of Unified Measurement

Updated Category News Views 163

Unlocking Sales Potential: The Power of Unified Measurement Marketing teams are faced with the challenge of demonstrating their impact amidst shifting sales channels. With the rise of platforms like Amazon, TikTok Shop, and other marketplaces, traditional measurement tools have fallen short, often focusing solely on .com sales. This shortfall can lead to up to 42% of...

Continue Reading
Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Updated Category News Views 81

Rigel Pharmaceuticals to Announce Fourth Quarter Results Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has made an important announcement detailing its plans to share its financial performance for the fourth quarter and the full year of 2024. This financial disclosure is scheduled to occur after the market closes on a day soon approaching in March. Details on the Conference...

Continue Reading
DENSO Partners for Michigan Workforce Development Initiatives

Updated Category News Views 213

DENSO Collaborates to Enhance Michigan's Workforce DENSO, a prominent mobility supplier, is making significant strides in workforce development by partnering with local businesses and organizations in Michigan. This collaboration has successfully secured over $550,000 in workforce training grants aimed at supporting leadership and skilled trades upskilling in the region....

Continue Reading